Overview of the CLLR3 trial of obinutuzumab
Tsunami of evidence in CLL
TGR-1202 in CLL and non-Hodgkin lymphoma
Why is personalized medicine important for CLL?
Why do charities need to keep funding research into leukemia and blood cancer in general?